Octagon Capital Advisors as of Sept. 30, 2023
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 37 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 24.6 | $160M | 4.2M | 38.04 | |
| Roivant Sciences SHS (ROIV) | 7.8 | $51M | 4.4M | 11.68 | |
| Cymabay Therapeutics Put Option | 7.2 | $47M | 3.1M | 14.91 | |
| Verona Pharma Sponsored Ads (VRNA) | 5.9 | $39M | 2.4M | 16.30 | |
| Immunovant Put Option (IMVT) | 5.9 | $38M | 1.0M | 38.39 | |
| Arcus Biosciences Incorporated (RCUS) | 5.4 | $35M | 2.0M | 17.95 | |
| Insmed Com Par $.01 (INSM) | 5.0 | $32M | 1.3M | 25.25 | |
| Mirati Therapeutics | 4.4 | $29M | 655k | 43.56 | |
| Bridgebio Pharma (BBIO) | 3.9 | $26M | 972k | 26.37 | |
| Celldex Therapeutics Com New (CLDX) | 3.2 | $21M | 760k | 27.52 | |
| 89bio (ETNB) | 2.9 | $19M | 1.2M | 15.44 | |
| Reneo Pharmaceuticals (RPHM) | 2.7 | $17M | 2.3M | 7.62 | |
| Miragen Therapeutics (VRDN) | 2.5 | $16M | 1.1M | 15.34 | |
| An2 Therapeutics (ANTX) | 2.1 | $14M | 868k | 16.08 | |
| Amylyx Pharmaceuticals (AMLX) | 2.0 | $13M | 695k | 18.31 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.3 | $8.8M | 2.8M | 3.16 | |
| Alpine Immune Sciences (ALPN) | 1.3 | $8.6M | 750k | 11.45 | |
| Gossamer Bio (GOSS) | 1.0 | $6.8M | 8.2M | 0.83 | |
| Aerovate Therapeutics (AVTE) | 1.0 | $6.7M | 497k | 13.57 | |
| Dianthus Therapeutics (DNTH) | 1.0 | $6.6M | 480k | 13.67 | |
| Dyne Therapeutics (DYN) | 1.0 | $6.2M | 693k | 8.96 | |
| Pmv Pharmaceuticals (PMVP) | 0.9 | $5.6M | 904k | 6.14 | |
| Inozyme Pharma (INZY) | 0.8 | $5.5M | 1.3M | 4.20 | |
| Xilio Therapeutics (XLO) | 0.8 | $4.9M | 2.3M | 2.11 | |
| Annexon (ANNX) | 0.7 | $4.8M | 2.1M | 2.36 | |
| Glycomimetics (GLYC) | 0.7 | $4.5M | 3.0M | 1.50 | |
| Viking Therapeutics (VKTX) | 0.6 | $4.2M | 375k | 11.07 | |
| Monte Rosa Therapeutics (GLUE) | 0.6 | $3.9M | 813k | 4.79 | |
| Jasper Therapeutics | 0.5 | $3.1M | 4.5M | 0.70 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $3.1M | 476k | 6.47 | |
| Vir Biotechnology (VIR) | 0.5 | $3.0M | 325k | 9.37 | |
| Travere Therapeutics Call Option (TVTX) | 0.4 | $2.7M | 300k | 8.94 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 0.3 | $2.1M | 1.9M | 1.09 | |
| Oric Pharmaceuticals (ORIC) | 0.2 | $1.2M | 205k | 6.05 | |
| Iteos Therapeutics (ITOS) | 0.2 | $1.1M | 102k | 10.95 | |
| Bionomics Ads (BNOX) | 0.1 | $454k | 168k | 2.70 | |
| Hepion Pharmaceuticals Com New (HEPA) | 0.1 | $337k | 68k | 4.99 |
